Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Mark Hathaway

Obstetrics & Gynecology Washington, DC Medical Doctor

NPI 1720068133 CMS profile 169212

1225 4Th St Ne, Washington, DC 20002

Open in the dashboard

General payments

$179,560

331 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Mark Hathaway of Washington, DC is reported in the CMS Open Payments database as having received $179,560 across 331 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Obstetrics & Gynecology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $21,244 27
2024 General $44,214 88
2023 General $13,594 34
2022 General $27,503 58
2021 General $29,406 48
2020 General $9,633 16
2019 General $33,967 60

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Mark Hathaway
  • Obstetrics & Gynecology median
  • Middle half of Obstetrics & Gynecology
  • National median

In program year 2025, general payments to Mark Hathaway were reported at $21,244. Among 21,306 Obstetrics & Gynecology profiles paid that year, the median was $158 and the middle half received between $51 and $401.

Show as a table
Year Mark Hathaway Obstetrics & Gynecology median Middle half National median
2019 $33,967 $172 $62–$391 $163
2020 $9,633 $94 $36–$222 $114
2021 $29,406 $136 $42–$369 $132
2022 $27,503 $160 $50–$433 $149
2023 $13,594 $169 $56–$423 $160
2024 $44,214 $152 $50–$371 $164
2025 $21,244 $158 $51–$401 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Organon LLC $107,189 209 payments
  2. Bayer HealthCare Pharmaceuticals Inc. $31,517 50 payments
  3. Merck Sharp & Dohme Corporation $22,397 46 payments
  4. CooperSurgical, Inc. $9,410 9 payments
  5. Afaxys, Inc. $5,963 6 payments
  6. Medicines360 $3,086 11 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for serving as faculty or as a speaker for a medical education program $84,822 140 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $63,153 47 payments
  3. Consulting Fee $16,337 19 payments
  4. Travel and Lodging $7,356 53 payments
  5. Honoraria $5,963 6 payments
  6. Food and Beverage $1,881 65 payments
  7. Education $48 1 payment
Products named General payments · program years 2019–2025
  1. NEXPLANON Etonogestrel $67,671 135 payments
  2. NEXPLANON Womens Health $22,397 46 payments
  3. Nexplanon Womens Health $20,134 31 payments
  4. Kyleena Women's Health $13,666 23 payments
  5. Kyleena Womens Health $13,558 12 payments
  6. Mirena $11,013 11 payments
  7. Paragard $9,410 9 payments
  8. Liletta $3,086 11 payments
  9. Medroxyprogesterone $2,625 2 payments
  10. Skyla $1,750 5 payments
  11. Other $2,016 7 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

331 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Obstetrics & Gynecology in District of Columbia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record